secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sanara MedTech Inc. (SMTI)
CIK:        0000714256
Form:       8-K
Filed at:   2026-09-30T23:48:20+00:00
Accession:  0001213900-26-105390
Event type: m_and_a
Sentiment:  positive
Materiality: 0.70
Item codes: 5.07, 8.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Sanara shareholders approve MiMedx merger; HSR waiting period runs to Oct 15 after refiling
--------------------------------------------------------------------------------

- Shareholders approved the merger with MiMedx at the Sept 30, 2026 special meeting: 6,372,989 votes for, 1,944 against and 36,494 abstained.
- Advisory vote on merger-related executive compensation passed 5,841,470 for, 75,247 against and 494,710 abstained.
- MiMedx withdrew and refiled its HSR notification Sept 15, 2026, starting a new 30-day waiting period expiring 11:59 p.m. ET Oct 15, 2026.
- 6,411,427 shares (69.78% of the 9,188,035 outstanding as of the Sept 1 record date) were present, so the adjournment proposal was not needed.
- Merger Agreement dated July 29, 2026 calls for Mustang Merger Sub to merge into Sanara, which survives as a wholly-owned MiMedx subsidiary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/714256/000121390026105390/0001213900-26-105390-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/714256/000121390026105390/ea0307287-8k_sanara.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-105390

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer